High-resolution mass spectrometry assay for quantifying ceramides and dihydroceramides in the cerebrospinal fluid from patients who experienced intracranial infection after craniotomy-Reference-Cited by-同舟云学术

High-resolution mass spectrometry assay for quantifying ceramides and dihydroceramides in the cerebrospinal fluid from patients who experienced intracranial infection after craniotomy

Published:2022-09 Issue: Volume:219 Page:114907
ISSN:0731-7085
Container-title:Journal of Pharmaceutical and Biomedical Analysis
language:en
Short-container-title:Journal of Pharmaceutical and Biomedical Analysis

Author:

Shi Jiawei,Wang Tingting,Guo Haiyang,Li Chen,Li Li,Jin Yuting,Chen Haizhen,Huang Jing

Funder

Jilin Scientific and Technological Development Program

Publisher

Elsevier BV

Subject

Clinical Biochemistry,Spectroscopy,Drug Discovery,Pharmaceutical Science,Analytical Chemistry

Reference35 articles.

1. Role of bioactive sphingolipids in physiology and pathology;Gomez-Larrauri;Essays Biochem.,2020

2. Sphingolipids in Alzheimer's disease, how can we target them;Crivelli;Adv. Drug Deliv. Rev.,2020

3. Identification of androgen receptor metabolic correlome reveals the repression of ceramide kinase by androgens;Camacho;Cancers,2021

4. Serum ceramide concentrations are associated with depression in patients after ischemic stroke-A two-center case-controlled study;Hong;Clin. Chim. Acta,2021

5. Ceramide biomarkers predictive of cardiovascular disease risk increase in healthy older adults after bed rest;Petrocelli;J. Gerontol. A Biol. Sci. Med. Sci.,2020

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Characteristics of intracranial infection in patients after neurosurgery, and the influence of rational use of antibiotics;TROP J PHARM RES;2023